TriangleFOR PATIENTS · SOURCE READING
Targeted therapy
Source: Retinoblastoma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 7, 2021 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview / New types of treatment are being tested in clinical trials.
Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells. Targeted therapies usually cause less harm to normal cells than chemotherapy or radiation therapy do.
Source links and citations
Oncolytic virus therapy: This treatment uses a virus that infects and breaks down cancer cells but not normal cells. An oncolytic adenovirus targeting the RB1 gene is injected into the tumor and may have anticancer effects in retinoblastoma. Targeted therapy is being studied for the treatment of retinoblastoma that has progressed or red.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice